DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 4Dr. Reddy's Laboratories
02 5Centocor
03 1Eqova
04 26Janssen-Cilag
05 10Johnson & Johnson Innovative Medicine
06 1Laurus Labs
07 1National Pharma
08 1Sandoz B2B
09 6Tecnimede
10 3Teva Pharmaceutical Industries
11 2Unichem Laboratories Limited
12 2Zydus Pharmaceuticals
Reset all filters
01 1Canagliflozin 100Mg 30 Joined' Oral Use
02 1Canagliflozin 300Mg 30 Joined' Oral Use
03 1Canagliflozin+Metformin 150+850Mg 60 Units Oral Use
04 1Canagliflozin+Metformin+1.000150 Mg 60 Units Oral Use
05 1Canagliflozin+Metformin+1.00050 Mg 60 Units Oral Use
06 1Canagliflozin+Metformin+85050 Mg 60 Units Oral Use
07 28Film Coated Tablet
08 4Oral Solid Dosage Form
09 5TABLET
10 4TABLET, EXTENDED RELEASE;ORAL
11 2TABLET; ORAL
12 9TABLET;ORAL
13 4Tablet
Reset all filters
01 6Allowed
02 6Approved
03 10Authorized
04 2Generic
05 4Lead Market Dossiers- Filed
06 5Prescription
07 10RX
08 19Blank
Reset all filters
01 5CANAGLIFLOZIN
02 2Canagliflozina Teva
03 7INVOKAMET
04 4INVOKAMET XR
05 4INVOKANA
06 4Invocated
07 6Invokana
08 12Vokanamet
09 4Vokanamet
10 14Blank
Reset all filters
01 5Canada
02 8India
03 6Italy
04 6Portugal
05 10Spain
06 6Sweden
07 6Switzerland
08 15USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 150MG; 1G
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 150MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 50MG; 1G
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 50MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : INVOKANA
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2013-03-29
Application Number : 204042
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVOKANA
Dosage Form : TABLET;ORAL
Dosage Strength : 300MG
Packaging :
Approval Date : 2013-03-29
Application Number : 204042
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Brand Name : INVOKAMET
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG;500MG
Packaging :
Approval Date : 2014-08-08
Application Number : 204353
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Brand Name : INVOKAMET
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG;1GM
Packaging :
Approval Date : 2014-08-08
Application Number : 204353
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Brand Name : INVOKAMET
Dosage Form : TABLET;ORAL
Dosage Strength : 150MG;500MG
Packaging :
Approval Date : 2014-08-08
Application Number : 204353
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Brand Name : INVOKAMET
Dosage Form : TABLET;ORAL
Dosage Strength : 150MG;1GM
Packaging :
Approval Date : 2014-08-08
Application Number : 204353
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Brand Name : INVOKAMET XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG;500MG
Packaging :
Approval Date : 2016-09-20
Application Number : 205879
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Brand Name : INVOKAMET XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG;1GM
Packaging :
Approval Date : 2016-09-20
Application Number : 205879
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Brand Name : INVOKAMET XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 150MG;500MG
Packaging :
Approval Date : 2016-09-20
Application Number : 205879
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Brand Name : INVOKAMET XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 150MG;1GM
Packaging :
Approval Date : 2016-09-20
Application Number : 205879
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : CANAGLIFLOZIN
Dosage Form : TABLET;ORAL
Dosage Strength : 300MG
Packaging :
Approval Date :
Application Number : 210503
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : CANAGLIFLOZIN
Dosage Form : TABLET; ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 210297
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : CANAGLIFLOZIN
Dosage Form : TABLET; ORAL
Dosage Strength : 300mg
Packaging :
Approval Date :
Application Number : 210451
Regulatory Info :
Registration Country : USA
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info :
Registration Country : USA
Brand Name : CANAGLIFLOZIN
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 210541
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : CANAGLIFLOZIN
Dosage Form : TABLET;ORAL
Dosage Strength : 300MG
Packaging :
Approval Date :
Application Number : 210541
Regulatory Info :
Registration Country : USA